Impact of community pharmacist antibiotic prescribing for minor ailments: an interrupted time series analysis
Leung V, Langford B, Brown KA, Ghahramani D, Hoang J, Oberai A, Tadrous M, Daneman N, Saqib K, Schwartz K. BMJ Open. 2025; 15(11): e107109.
Publications
Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study
Torabi A, Chu C, Abdul Aziz Y, Yada N, Chaudhry S, Wang T, Gomes T, Tadrous M. Can Pharm J (Ott). 2025; 17151635251358873. Epub 2025 Aug 22.
Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study
Iskandar RJ, Tadrous M, Nguyen P, Dolovich L, Green M, Frymire E, Drucker AM. Br J Dermatol. 2025; Apr 2 [Epub ahead of print].
Hyponatremia-associated hospital visits are not reduced by early electrolyte testing in older adults starting antidepressants
Lane NE, Bai L, Seitz DP, Juurlink DN, Paterson JM, Guan J, Stukel TA. J Am Geriatr Soc. 2024; Apr 25 [Epub ahead of print].
A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
Schmidt RA, Everett K, Perez-Brumer A, Strike C, Rush B, Gomes T. Addiction. 2024; Mar 13 [Epub ahead of print].
Initiations of safer supply hydromorphone increased during the COVID-19 pandemic in Ontario: an interrupted time series analysis
Young S, Gomes T, Kolla G, McCormack D, Dodd Z, Raboud J, Bayoumi AM. PLoS One. 2023; 18(12):e0295145. Epub 2023 Dec 19.
Unintentional pediatric poisonings before and during the COVID-19 pandemic: a population-based study
Myran DT, Gaudreault A, McCarthy SDS, Pugliese M, Tanuseputro P, Finkelstein Y. Am J Emerg Med. 2023; Dec 1 [Epub ahead of print].
Predictive risk modelling of high resource users under different prescription drug coverage policies in Ontario and Manitoba, Canada
Kornas K, Sarkar J, Fransoo R, Rosella LC. BMC Health Serv Res. 2023; 23(1):768. Epub 2023 Jul 19.
Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysis
Chang A, Chaudhry S, McCormack D, Gomes T, Shivji A, Tadrous M. Can Pharm J (Ott). 2022; Oct 12 [Epub ahead of print].
The Ontario Pharmacy Evidence Network Interactive Atlas of Professional Pharmacist Services
Cadarette SM, He N, Chaudhry M, Dolovich L. Can Pharm J (Ott). 2021; 154(3):153-9. Epub 2021 May 28.